You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -9,941.0% | -5,110.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -2.5 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 224.8 | 182.7 |
| Price / Book value | 2.4 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -46.0% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | 0.08 | -4.55 | -4.40p | -6.8 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 0.16 | -6.31 | -4.54p | -11.5 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 0.15 | -7.00 | -4.75p | -35.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.08 | -7.96 | -5.19p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.10 | -4.88 | -2.87p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.10 | -5.11 | -2.76p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 0.10 | -5.36 | -2.91p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| ImmuPharma and Avion to proceed with Lupuzor phase 3 trial Sharecast News | 06 Feb |
|---|---|
| ImmuPharma says not looking to raise funds Sharecast News | 11 Dec |
| ImmuPharma shares soar as it teams up with Avion on Lupuzor Sharecast News | 28 Nov |
| Incanthera plc – Admission to trading on NEX | 28-Feb-20 07:11 |
|---|---|
| Price Monitoring Extension | 21-Feb-20 16:35 |
| Incanthera announces Rule 23 Notice re NEX listing | 17-Feb-20 08:01 |
| Second Price Monitoring Extn | 12-Feb-20 16:42 |
| Price Monitoring Extension | 12-Feb-20 16:36 |